Authors
Shahrzad Molavinia, Saeedeh Shariati, Shokooh Mohtadi, Mohammad Javad Khodayar, Dian Dayer
Published in
International journal of environmental health research. Pages 1-12. Jun 29, 2026. Epub Jun 29, 2026.
Abstract
Acrylamide (ACR), a potential neurotoxin, is produced during industrial and food processing. The mechanisms of ACR neurotoxicity are still under debate, and effective strategies need to be investigated. We examined the neuroprotective potential of losartan (LOS), an antihypertensive drug, against ACR-induced neurotoxicity. PC12 cells were treated with concentrations of LOS (10, 20, and 50 μM) for 24 h and then exposed to ACR (5 mM) for a further 24 h. Antioxidant markers (SOD and CAT) and oxidative damage markers (ROS and TBARS) were measured. Real-time PCR was used to examine the mRNA expression of Bax and Bcl-2. Western blotting was used to evaluate the protein expression of Nrf2, Keap1, HO-1, as well as total and cleaved caspase-3. Exposure to ACR caused a significant increase in ROS and TBARS levels and reduced activities of SOD and CAT. Exposure to ACR affected the mRNA expression of key apoptotic regulators Bax and Bcl-2, resulting in a higher Bax/Bcl-2 expression. Furthermore, ACR elevated the protein expression of total and cleaved caspase-3 and Nrf2, while decreasing Keap1 levels. ACR-induced changes were reversed by LOS treatment. The findings demonstrated that LOS can protect PC12 cells from ACR-induced neurotoxicity by enhancing antioxidant defenses and modulating apoptotic signaling.
PMID:
42366942
Bibliographic data and abstract were imported from PubMed on 29 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0